A symposium on interventional MRI scheduled to take place lastmonth was canceled due to the small number of registrants, accordingto one of the organizers of the event. The cancellation couldbe a sign that one of MRI's most promising new clinical
A symposium on interventional MRI scheduled to take place lastmonth was canceled due to the small number of registrants, accordingto one of the organizers of the event. The cancellation couldbe a sign that one of MRI's most promising new clinical applicationsis not yet ready for prime time.
The National Symposium on Interventional MRI was scheduledfor July 27-30 in Marina del Rey, CA. It was to be the secondannual symposium; the first was held last year following the Societyof Magnetic Resonance meeting in San Francisco.
But interventional MRI apparently is not yet mature enoughto warrant a stand-alone conference. Organizers decided to pullthe plug after fewer than 20 registrations came in, well shortof the 100 to 200 that were hoped for, according to Dr. LawrenceMuroff of Educational Symposia in Tampa, FL. Educational Symposiaco-sponsored the event, along with the Center for InterventionalMRI at UCLA Medical Center.
"I think that interventional MRI is a concept slightlyahead of its time," Muroff said. "A lot of people havebeen generating excitement in the area, but few have machinescapable of doing those procedures."
Muroff declined to estimate when the symposium would be rescheduled,but said his group was interested in sponsoring the meeting againonce it feels clinical interest is there.
Study: AI Boosts Ultrasound AUC for Predicting Thyroid Malignancy Risk by 34 Percent Over TI-RADS
February 17th 2025In a study involving assessment of over 1,000 thyroid nodules, researchers found the machine learning model led to substantial increases in sensitivity and specificity for estimating the risk of thyroid malignancy over traditional TI-RADS and guidelines from the American Thyroid Association.
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
February 14th 2025For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.